Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02530112 · ClinicalTrials.gov registry record
Functional Outcome Measures for Head and Neck Patients
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Terminated
- Registry status
- 1,000
- Enrollment target
NCT02530112 is a clinical trial that was terminated before completion, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 1,000 participants.
The verdict
NCT02530112 was terminated before completion, sponsored by Abramson Cancer Center at Penn Medicine.
- TERMINATED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The objective of this study is to identify outcome measures for cancer control in Head and Neck cancer patient populations at the University of Pennsylvania (HUP, PAH, Presby) by administering various functional outcome surveys and questionnaires about their reconstructive surgery. We hope to ultimately develop a QOL indicator that will reflect the impact of reconstructive surgery on patient's quality of life, and help with therapeutic interventions and explanation of expectations prior to surgery.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2014-02-02 |
| Est. Completion | 2024-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02530112
The ClinicalTrials.gov registry entry for NCT02530112 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT02530112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02530112 about?
NCT02530112 is a clinical study titled "Functional Outcome Measures for Head and Neck Patients". The objective of this study is to identify outcome measures for cancer control in Head and Neck cancer patient populations at the University of Pennsylvania (HUP, PAH, Presby) by administering various functional outcome surveys and questionnaires about their reconstructive surgery. We hope to ultima...
What is the current status of trial NCT02530112?
This trial is currently terminated. The enrollment target is 1,000 participants. The study started on 2014-02-02. Estimated completion is 2024-12.
What interventions are being tested in trial NCT02530112?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT02530112?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.